Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells

2017 Kim, 2014, HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability, Gut, 63, 1325, 10.1136/gutjnl-2013-305517 Tong, 2016, Overview of hepatitis B viral replication and genetic variability, J Hepatol, 64, S4, 10.1016/j.jhep.2016.01.027 Tu, 2017, HBV DNA integration: molecular mechanisms and clinical implications, Viruses, 9, 75, 10.3390/v9040075 Pollicino, 2021, HBV-integration studies in the clinic: role in the natural history of infection, Viruses, 13, 368, 10.3390/v13030368 van Buuren, 2022, Targeted long-read sequencing reveals clonally expanded HBV-associated chromosomal translocations in patients with chronic hepatitis B, JHEP Rep, 4 Jiang, 2012, The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients, Genome Res, 22, 593, 10.1101/gr.133926.111 Mason, 2016, HBV DNA integration and clonal hepatocyte expansion in chronic hepatitis B patients considered immune tolerant, Gastroenterology, 151, 986, 10.1053/j.gastro.2016.07.012 Budzinska, 2018, Sequence analysis of integrated hepatitis B virus DNA during HBeAg-seroconversion, Emerg Microbes Infect, 7, 142, 10.1038/s41426-018-0145-7 Sung, 2012, Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma, Nat Genet, 44, 765, 10.1038/ng.2295 Zhao, 2016, Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma, Nat Commun, 7 Péneau, 2022, Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma, Gut, 71, 616, 10.1136/gutjnl-2020-323153 Wooddell, 2017, RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg, Sci Transl Med, 9, 10.1126/scitranslmed.aan0241 Meier, 2021, Ubiquitous expression of HBsAg from integrated HBV DNA in patients with low viral load, J Hepatol, 75, 840, 10.1016/j.jhep.2021.04.051 Loglio, 2021, Novel therapies that may cure chronic hepatitis B virus, Clin Liver Dis, 25, 875, 10.1016/j.cld.2021.07.001 Marcellin, 2008, Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B, N Engl J Med, 359, 2442, 10.1056/NEJMoa0802878 Gordon, 2013, Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load, Hepatology, 58, 505, 10.1002/hep.26277 2017, EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection, J Hepatol, 67, 370, 10.1016/j.jhep.2017.03.021 Hong, 2021, Characterization of hepatitis B precore/core-related antigens, J Virol, 95, 10.1128/JVI.01695-20 Taube, 2021, Multi-institutional TSA-amplified multiplexed immunofluorescence reproducibility evaluation (MITRE) study, J Immunother Cancer, 9 Ronneberger, 2015, U-Net: convolutional networks for biomedical image segmentation, 234 van Bömmel, 2015, Serum hepatitis B virus RNA levels as an early predictor of hepatitis B e antigen seroconversion during treatment with polymerase inhibitors, Hepatology, 61, 66, 10.1002/hep.27381 Montanari, 2022, Multi-parametric analysis of human livers reveals variation in intrahepatic inflammation across phases of chronic hepatitis B infection, J Hepatol, 77, 332, 10.1016/j.jhep.2022.02.016 Hsu, 1988, Correlation of hepatocyte HBsAg expression with virus replication and liver pathology, Hepatology, 8, 749, 10.1002/hep.1840080408 Zhang, 2016, In situ analysis of intrahepatic virological events in chronic hepatitis B virus infection, J Clin Invest, 126, 1079, 10.1172/JCI83339 Naumov, 1984, Relationship between expression of hepatitis B virus antigens in isolated hepatocytes and autologous lymphocyte cytotoxicity in patients with chronic hepatitis B virus infection, Hepatology, 4, 63, 10.1002/hep.1840040111 Hsu, 1987, Biologic and prognostic significance of hepatocyte hepatitis B core antigen expressions in the natural course of chronic hepatitis B virus infection, J Hepatol, 5, 45, 10.1016/S0168-8278(87)80060-0 van Buuren, 2022, Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infection, JHEP Rep, 4 Ramakrishna, 2008, Correlation of hepatocyte expression of hepatitis B viral antigens with histological activity and viral titer in chronic hepatitis B virus infection: an immunohistochemical study, J Gastroenterol Hepatol, 23, 1734, 10.1111/j.1440-1746.2008.05416.x Safaie, 2016, Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma, World J Gastroenterol, 22, 3404, 10.3748/wjg.v22.i12.3404 Yang, 1999, Integration of hepadnavirus DNA in infected liver: evidence for a linear precursor, J Virol, 73, 9710, 10.1128/JVI.73.12.9710-9717.1999 Freitas, 2014, Support of the infectivity of hepatitis delta virus particles by the envelope proteins of different genotypes of hepatitis B virus, J Virol, 88, 6255, 10.1128/JVI.00346-14 Budzinska, 2018, Cellular genomic sites of hepatitis B virus DNA integration, Genes (Basel), 9, 365, 10.3390/genes9070365 Gowans, 1985, Widespread presence of cytoplasmic HBcAg in hepatitis B infected liver detected by improved immunochemical methods, J Clin Pathol, 38, 393, 10.1136/jcp.38.4.393 Chang, 2018, Ground glass hepatocytes provide targets for therapy or prevention of hepatitis B virus-related hepatocellular carcinoma, AIMS Med Sci, 5, 90, 10.3934/medsci.2018.2.90 Tsai, 2016, Resistance of ground glass hepatocytes to oral antivirals in chronic hepatitis B patients and implication for the development of hepatocellular carcinoma, Oncotarget, 7, 27724, 10.18632/oncotarget.8388 Hsu, 2022, Inhibition of viral replication reduces transcriptionally active distinct hepatitis B virus integrations with implications on host gene dysregulation, Gastroenterology, 162, 1160, 10.1053/j.gastro.2021.12.286 Grudda, 2022, Integrated hepatitis B virus DNA maintains surface antigen production during antivirals, J Clin Invest, 132, 10.1172/JCI161818 Burdette, 2022, Ongoing viral replication and production of infectious virus in patients with chronic hepatitis B virus suppressed below the limit of quantitation on long-term nucleos(t)ide therapy, PLoS One, 17, 10.1371/journal.pone.0262516 Werle-Lapostolle, 2004, Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy, Gastroenterology, 126, 1750, 10.1053/j.gastro.2004.03.018 Huang, 2021, Rapid turnover of hepatitis B virus covalently closed circular DNA indicated by monitoring emergence and reversion of signature-mutation in treated chronic hepatitis B patients, Hepatology, 73, 41, 10.1002/hep.31240 Lau, 1991, Export of intracellular HBsAg in chronic hepatitis B virus infection is related to viral replication, Hepatology, 14, 416, 10.1002/hep.1840140303 Thompson, 2010, Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers, Hepatology, 51, 1933, 10.1002/hep.23571 Chu, 1987, Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection. Hepatocyte with cytoplasmic/membranous hepatitis B core antigen as a possible target for immune hepatocytolysis, Gastroenterology, 92, 220, 10.1016/0016-5085(87)90863-8